石斛养胃汤联合奥美拉唑肠溶胶囊对慢性萎缩性胃炎患者炎症因子及氧化应激水平的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.3

基金项目:


Effects of Shihu Yangwei Tang Combined with Omeprazole Enteric-Soluble Capsules on Inflammatory Factors and Oxidative Stress Levels in Patients with Chronic Atrophic Gastritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察石斛养胃汤联合奥美拉唑肠溶胶囊对慢性萎缩性胃炎胃阴不足证患者炎症因子与氧化应激水平的影响。方法:选取80 例慢性萎缩性胃炎胃阴不足证患者,按随机数字表法分为对照组及观察组各40 例,对照组给予奥美拉唑肠溶胶囊口服,观察组给予奥美拉唑肠溶胶囊联合石斛养胃汤治疗,2 组疗程均为4 周。比较2 组临床疗效,观察2 组治疗前后中医证候评分、炎症因子[C-反应蛋白(CRP)、白细胞介素-6(IL-6)]与氧化应激因子[超氧化物歧化酶(SOD)、丙二醛(MDA)]水平的变化,比较2 组不良反应发生率。结果:对照组临床疗效总有效率为72.50%,观察组临床疗效总有效率为95.00%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组食欲不振、胃脘胀痛及胃刺痛的中医证候评分均较治疗前下降(P<0.05);观察组上述3 项评分均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组CRP、IL-6 水平均较治疗前降低(P<0.05);观察组CRP、IL-6 水平均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组SOD 水平均较治疗前上升,MDA 水平均较治疗前下降,差异均有统计学意义(P<0.05);治疗后,观察组SOD 水平高于对照组,MDA 水平低于对照组,差异均有统计学意义(P<0.05)。治疗期间,对照组不良反应发生率为12.50%;观察组不良反应发生率为5.00%。2 组比较,差异无统计学意义(P>0.05)。结论:石斛养胃汤联合奥美拉唑肠溶胶囊治疗慢性萎缩性胃炎胃阴不足证的疗效较好,可缓解患者临床症状,降低机体炎症反应,该联合用药的方案安全性较高。

    Abstract:

    Abstract:Objective:To observe the effects of the therapy of Shihu Yangwei tang combined with omeprazole entericsoluble capsules on inflammatory factors and levels of oxidative stress in patients with chronic atrophic gastritis with deficiency of stomach yin syndrome. Methods:A total of 80 cases with chronic atrophic gastritis with deficiency of stomach yin syndrome were selected and divided into the control group and the observation group according to random number table method, with 40 cases in each group. The control group was given omeprazole enteric- soluble capsules orally, and the observation group was given omeprazole enteric-soluble capsules combined with Shihu Yangwei tang. The treatment course of both groups was four weeks. The clinical effects in the two groups were compared,and the Chinese medicine syndrome scores, the levels of inflammatory factors including C- reactive protein(CRP) and interleukin- 6(IL- 6), and oxidative stress factors including superoxide dismutase(SOD) and malondialdehyde(MDA) before and after treatment as well as the incidence of adverse reactions in the two groups were observed. Results:The total effective rate of clinical effect was 72.50% in the control group and 95.00% in the observation group,the difference being significant(P<0.05). After treatment,the scores of Chinese medicine syndromes such as poor appetite, pain and distention in the stomach cavity and stabbing pain in the stomach in both groups were decreased when compared with those before treatment(P<0.05). The scores in the observation group were lower than those in the control group,differences being significant(P<0.05). After treatment,the levels of CRP and IL- 6 in both groups were decreased when compared with those before treatment(P<0.05);and the two levels in the observation group were lower than those in the control group,differences being significant(P<0.05). After treatment,the SOD levels were increased and MDA levels were decreased in both groups when compared with those before treatment, differences being significant(P<0.05). After treatment, the SOD level in the observation group was higher than that in the control group, and the MDA level was lower, differences being significant(P<0.05). During treatment, the incidence of adverse reactions in the control group was 12.50% and 5.00% in the observation group,there being no significant difference between the two groups(P>0.05). Conclusion: The therapy of Shihu Yangwei tang combined with omeprazole entericsoluble capsules has a significant therapeutic effect on the treatment of chronic atrophic gastritis with deficiency of stomach yin syndrome,which can relieve the clinical symptoms and reduce the inflammatory responses of patients,with relatively great safety.

    参考文献
    相似文献
    引证文献
引用本文

尹意婷,鲁月琴,何月敏.石斛养胃汤联合奥美拉唑肠溶胶囊对慢性萎缩性胃炎患者炎症因子及氧化应激水平的影响[J].新中医,2022,54(5):108-112

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-03-10
  • 出版日期: